TP53 genomic status regulates sensitivity of gastric cancer cells to the histone methylation inhibitor 3-deazaneplanocin A (DZNep)

by Cheng, L.L., Itahana, Y., Lei, Z.D., Chia, N.-Y., Wu, Y., Yu, Y., Zhang, S.L., Thike, A.A., Pandey, A., Rozen, S., Voorhoeve, P.M., Yu, Q., Tan, P.H., Bay, B.H., Itahana, K., Tan, P.
Published 2014

Integrated epigenomics identifies BMP4 as a modulator of cisplatin sensitivity in gastric cancer

by Ivanova, T., Zouridis, H., Wu, Y., Cheng, L.L., Tan, I.B., Gopalakrishnan, V., Ooi, C.H., Lee, J., Qin, L., Wu, J., Lee, M., Rha, S.Y., Huang, D., Liem, N., Yeoh, K.G., Yong, W.P., Teh, B.T., Tan, P.
Published 2014

Oncogenic pathway combinations predict clinical prognosis in gastric cancer

by Ooi, C.H., Tan, P., Ivanova, T., Wu, J., Lee, M., Tao, J., Koo, J.H., Gopalakrishnan, V., Zhu, Y., Lee, J., Ganesan, K., Tan, I.B., Tao, J., Ward, L., Grabsch, H., Cheng, L.L., Rha, S.Y., Chung, H.C., So, J., Soo, K.C., Lim, D., Chan, W.H., Wong, W.K., Bowtell, D., Boussioutas, A., Yeoh, K.G.
Published 2011